EDGAR Filing Documents for 0001171843-19-005142

Form 8-K - Current report:

SEC Accession No. 0001171843-19-005142

Filing Date

2019-08-05

Accepted

2019-08-05 11:32:21

Documents

Period of Report

2019-08-05

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_080519.htm	8-K	10831
2	PRESS RELEASE	exh_991.htm	EX-99.1	70047
	Complete submission text file	0001171843-19-005142.txt		82158

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 19997934
SIC: 2834 Pharmaceutical Preparations